Western blot analyses of ASS1 and phosphorylated CAD (p-CAD) in 12 paired clinical samples revelated that compared to non-tumor liver samples, ASS1 was notably downregulated, whereas CAD activation (p-CAD/CAD ratio) was upregulated in HCC tissues (Fig. 6B-C). Here, ASS1 is linked to hepatocellular carcinoma.